Effects of Clinicopathological Characteristics on the Survival of Patients Treated with PD-1/PD-L1 Inhibitor Monotherapy or Combination Therapy for Advanced Cancer: A Systemic Review and Meta-Analysis

Figure 3

Subgroup analysis for combination therapy. HR: hazard ratio; Y: yes; N: no.